Home Tags WLSU, OBES, -BRS

Tag: WLSU, OBES, -BRS

Today’s Health News

Longtime NIH Leader Francis Collins Retires

0
By India Edwards HealthDay Reporter MONDAY, March 3, 2025 (HealthDay News) -- Dr. Francis Collins, the famed geneticist who led the National Institutes of Health...

AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy

0

Most patients include dietary consumption of allergy-triggering foods after gaining tolerance

Mortality Increased With Hospital-Based Care for Hallucinogen Use

0

People with acute care involving hallucinogens have greater risk for death by unintentional drug poisoning, suicide

GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk

0

After adjustment for confounding variables, no increased risk seen for GLP-1 receptor agonists versus DPP-4 inhibitors, SGLT-2 inhibitors

AAN: Marine Microplastic Levels Linked to Cognitive, Other Disabilities

0

Higher prevalence rates of cognitive, mobility, self-care, and independent living disability seen for coastal counties with very high versus low MMLs

Today’s Health News

AAN: Prophylactic Zonisamide Effective in Pediatric Migraine

0

Significant reduction seen in median headache days per month in both intractable and nonintractable migraine groups

Psychosomatic Misdiagnosis Can Have Lasting Negative Impact on Patients

0

Findings seen for physical and mental health, as well as health care-seeking behaviors for people with systemic autoimmune rheumatic diseases

Ultra-Rapid Molecular-Genetic Assays Feasible for Tumor Classification During Surgery

0

Ultra-rapid digital droplet PCR can measure the levels of tumor cells in a tissue sample in about 15 minutes

Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors

0

Sotagliflozin can also significantly reduce the rate of myocardial infarction and stroke compared with placebo

One in Six Parents Support Teens Getting Nonsurgical Cosmetic Procedures

0

However, less than half of parents support procedures even for mental health or bullying concerns

FDA Makes Access to Clozapine Easier for Patients With Schizophrenia

0

Patients will no longer have to provide blood test results before filling their prescription

Patients Hospitalized With COVID-19 Face Higher Long-Term Risk for Death, Rehospitalization

0

Multiorgan consequences of COVID-19 persist through 30 months after discharge

Real-World Study Shows Effectiveness of Ixekizumab for Psoriasis

0

Significant clinical improvements seen with and without induction therapy, with faster initial response with induction

Higher Fish Intake Linked to Reduced Risk for MS Disability Worsening

0

More pronounced protective effects seen in patients who maintained consistent fish consumption during follow-up

Semaglutide May Reduce Craving in Alcohol Use Disorder

0

Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving